- Full Year 2023 Basilea Pharmaceutica AG Allschwil Earnings Call TranscriptFeb 13, 2024CHF36.5 (+8.79%)Earnings
- Basilea Pharmaceutica AG Allschwil to Acquire the Rights to Fosmanogepix from Amplyx Pharmaceuticals Inc Call TranscriptNov 13, 2023
- Half Year 2023 Basilea Pharmaceutica AG Allschwil Earnings Call TranscriptAug 15, 2023CHF47.35 (+11.67%)Earnings
- Full Year 2022 Basilea Pharmaceutica AG Earnings Call TranscriptFeb 14, 2023CHF49.55 (+3.55%)Earnings
- Half Year 2022 Basilea Pharmaceutica AG Earnings Call TranscriptAug 16, 2022CHF40.25 (-7.47%)Earnings
- Basilea Pharmaceutica AG to Discuss the ERADICATE Topline Results Call TranscriptJun 28, 2022
- Basilea Pharmaceutica AG at UBS Global Healthcare Conference TranscriptMay 24, 2022
- Full Year 2021 Basilea Pharmaceutica AG Earnings Call TranscriptFeb 15, 2022CHF41.72 (+4.04%)Earnings
- Half Year 2021 Basilea Pharmaceutica AG Earnings Call TranscriptAug 17, 2021CHF45.16 (-1.61%)Earnings
- Full Year 2020 Basilea Pharmaceutica AG Earnings Call TranscriptFeb 16, 2021CHF58.8 (-3.61%)Earnings
- Half Year 2020 Basilea Pharmaceutica AG Earnings Call TranscriptAug 11, 2020CHF49 (+4.66%)Earnings
- Basilea Pharmaceutica AG at UBS Global Healthcare Conference (Virtual) TranscriptMay 19, 2020
- Full Year 2019 Basilea Pharmaceutica AG Earnings Call TranscriptFeb 18, 2020CHF56.35 (-5.77%)Earnings
- Half Year 2019 Basilea Pharmaceutica AG Earnings Call TranscriptAug 20, 2019CHF39.16 (+5.90%)Earnings
- Basilea Pharmaceutica AG at UBS Global Healthcare Conference TranscriptMay 21, 2019
Half Year 2019 Basilea Pharmaceutica AG Earnings Call Transcript
Ladies and gentlemen, welcome to the Basilea Pharmaceutica's Half Year Results 2019 Conference Call and Live Webcast. I'm Sandra, the ChorusCall operator. (Operator Instructions) The conference must not be recorded for publication or broadcast. At this time, it's my pleasure to hand over to David Veitch, Chief Executive Officer. Please go ahead, sir.
Thank you. Hello. This is David Veitch, CEO of Basilea. I would like to welcome you all to our conference call and webcast, reviewing our financial results and key achievements for the first half year 2019 and also review our upcoming milestones and financial guidance for the full year 2019. I would like to mention that this call contains forward-looking statements.
This morning, we issued a press release and financial report on the results of the first half year 2019, and these documents are available on our website at basilea.com. Joining me today on the call are Adesh Kaul, our Chief Financial Officer; and Dr. Marc Engelhardt, our Chief Medical Officer.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)